CHD1 and prostate neoplasm: In both models, we found that CHD1 depletion significantly delayed the development and progression of PTEN-deficient prostate tumors and prolonged the survival of mice, providing genetic evidence supporting the essential roles of CHD1 in the context of PTEN defects (27).